iCAD to Participate in the iAccess Alpha Buyside Best Ideas Fall Conference 2024
![GlobeNewswire](../../../Content/images/providers/GN.png)
icad inc. (ICAD)
Last icad inc. earnings: 2/27 04:01 pm
Check Earnings Report
US:NASDAQ Investor Relations:
icadmed.com/financial-news-and-events.html
Company Research
Source: GlobeNewswire
NASHUA, N.H., Sept. 11, 2024 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD) (“iCAD” or the “Company”) a global leader on a mission to create a world where cancer can’t hide by providing clinically proven AI-powered breast health solutions, announced today that management is participating in the iAccess Alpha Buyside Best Ideas Fall Conference 2024 on September 24 and 25, 2024. CEO, Dana Brown and CFO, Eric Lonnqvist will deliver a company presentation at 11:00 am ET on September 24, and host one-on-one meetings the following day, September 25. To learn more about the iAccess Alpha Buyside Best Ideas Fall Conference 2024, or to register and schedule a one-on-one meeting with iCAD, please visit the conference website at https://www.iaccessalpha.com/home. The iCAD presentation will be webcast live and available for replay at https://www.webcaster4.com/Webcast/Page/3064/51217. The iCAD presentation will also be available on the company’s investor relations website under the Events & Ea
Show less
Read more
Impact Snapshot
Event Time:
ICAD
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
ICAD alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
ICAD alerts
High impacting icad inc. news events
Weekly update
A roundup of the hottest topics
ICAD
News
- iCAD, Inc. (NASDAQ: ICAD) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.MarketBeat
- iCAD Pre-Announces Estimated Q4 2024 RevenueGlobeNewswire
- SABCS 2024: New Research Assesses iCAD's Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse Populations [Yahoo! Finance]Yahoo! Finance
- SABCS 2024: New Research Assesses iCAD’s Image Based AI-Risk, Detection, and Breast Arterial Calcifications (BAC) Assessment Across Diverse PopulationsGlobeNewswire
- CORRECTION – iCAD Advances Fight Against Breast Cancer with FDA-cleared, Next-Generation AI Solutions and ProFound Health Partnership with Cascaid Health at RSNA 2024GlobeNewswire
ICAD
Sec Filings
- 2/7/25 - Form 4
- 2/7/25 - Form 4
- 2/7/25 - Form 4
- ICAD's page on the SEC website